Q1 2026 Holdings
Filed 2026-05-15 | 22 holdings | $351.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $92.1M | 1,746,264 | 26.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $76.6M | 1,130,501 | 21.8% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $30.1M | 1,673,420 | 8.6% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $26.4M | 4,131,299 | 7.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $25.6M | 2,144,844 | 7.3% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $17.2M | 3,497,948 | 4.9% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $12.8M | 643,382 | 3.6% |
| Onkure Therapeutics Inc(OKUR) | CLASS A COM | 68277Q105 | $11.8M | 2,839,674 | 3.3% |
| Jade Biosceinces Inc(JBIO) | COM NEW | 008064206 | $11.1M | 786,760 | 3.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $9.1M | 1,752,115 | 2.6% |
| Verastem Inc(VSTM) | COM | 92337C203 | $7.8M | 1,469,153 | 2.2% |
| Helus Pharma Inc.(HELP) | COM STK | 23256X407 | $7.4M | 1,540,266 | 2.1% |
| Leonabio, Inc.(LONA) | COMMON STOCK | 04746L203 | $6.5M | 634,539 | 1.9% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $4.0M | 595,744 | 1.1% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $3.9M | 1,139,363 | 1.1% |
| Cardif Oncology Inc(CRDF) | COM | 14147L108 | $2.9M | 1,762,084 | 0.8% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $2.0M | 315,052 | 0.6% |
| Karyopharm Therapeutics Inc(KPTI) | COMMON STOCK | 48576U205 | $1.6M | 287,826 | 0.5% |
| Jasper Therapeutics(JSPR) | COM | 471871202 | $1.2M | 1,411,492 | 0.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $966.6K | 234,039 | 0.3% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $865.0K | 5,406,345 | 0.2% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $855 | 1,425 | 0.0% |